Literature DB >> 31945905

An Instrumented Measurement Scheme for the Assessment of Upper Limb Function in Individuals with Friedreich Ataxia.

Khoa D Nguyen, Louise A Corben, Pubudu N Pathirana, Malcolm K Horne, Martin B Delatycki, David J Szmulewicz.   

Abstract

Continuous and objective assessment is essential for accurate monitoring of the progression of neurodegenerative conditions such as Friedreich ataxia. However, current clinical assessments predominantly rely on the ability of the affected individual to complete specific clinical tests which may not capture the intricate kinematic details associated with ataxia Moreover, such testing often consists of a level of subjectivity of the assessing clinician. In this paper, we propose an objective measuring instrument, in the form of a spoon, equipped with the Internet-of-Things (IoT) based system and relevant machine learning techniques to quantitatively assess impairment levels while engaged in routine daily activity. In a clinical study involving individuals diagnosed with Friedreich ataxia, movement patterns during a simulated eating task were captured and kinematic biomarkers were extracted that were consistent with the frequently-used clinical rating scales. Multivariate analysis of these biomarkers allows us to accurately classify individuals with Friedreich ataxia and control subjects to an accuracy of 91%. Furthermore, the kinematic information captured from the spoon can be used to introduce an alternative assessment scheme with a greater sensitivity to ataxic movements and with less inter-rater discrepancy.

Entities:  

Year:  2019        PMID: 31945905     DOI: 10.1109/EMBC.2019.8857107

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  1 in total

1.  The attitude of patients with progressive ataxias towards clinical trials.

Authors:  Gilbert Thomas-Black; Andrada Dumitrascu; Hector Garcia-Moreno; Julie Vallortigara; Julie Greenfield; Barry Hunt; Susan Walther; Mackenzie Wells; David R Lynch; Hugh Montgomery; Paola Giunti
Journal:  Orphanet J Rare Dis       Date:  2022-01-04       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.